نتایج جستجو برای: capecitabine

تعداد نتایج: 4646  

Journal: :Revista científica 2023

Colon cancer (CRC) is one of the most common types in world. In this study, effects Tarantula cubensis alcoholic extract (TCAE) and Capecitabine CRC were investigated. Wistar albino rats divided into eight groups with 12 animals each group: untreated healthy groups, treated TCAE or Capecitabine, both Capecitabine. Azoxymethane was used all groups. administered to relevant starting 15th week. Al...

2014
Alberto Bongiovanni Nada Riva Sebastiano Calpona Marianna Ricci Erica Gunelli Chiara Liverani Federico La Manna Alessandro De Vita Manuela Monti Stefano Severi Federica Pieri Elena Amadori Riccardo Galassi Davide Cavaliere Alberto Zaccaroni Andreas Tartaglia Veronica Lunedei Andrea Gardini Laura Mercatali Dino Amadori Toni Ibrahim

BACKGROUND We present a retrospective analysis of metronomic capecitabine in metastatic gastroenteropancreatic neuroendrocrine tumors (GEP-NETs). A review of the literature is also presented. METHODS From January 2007 to December 2013, ten patients with metastatic GEP-NETs (four pancreatic and six ileal) who progressed after treatment with somatostatin analogs and other cytotoxic agents recei...

2014
Meng Su Lu-Cheng Zhu Hang-Ping Wei Wen-Hua Luo Rui-Fang Lin Chang-Lin Zou

OBJECTIVE The aim of this paper was to compare the efficacy and safety of S-1-based and capecitabine-based preoperative chemoradiotherapy regimens in patients with locally advanced rectal cancer through a retrospective matched-pair analysis. MATERIALS AND METHODS Between Jan 2010 and Mar 2014, 24 patients with locally advanced rectal cancer who received preoperative radiotherapy concurrently ...

Journal: :Annals of palliative medicine 2021

Background: This study sought to test the effectiveness of EVOSKIN®Palm and sole moisturizing cream (PSMC) in preventing treating hand-foot syndrome (HFS) during capecitabine chemotherapy.

Journal: :Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2006
J P Machiels C Sempoux P Scalliet J C Coche B Coster J L Canon J Kerger E Van Cutsem M Peeters K Haustermans

3552 Background: Capecitabine has the potential to replace 5-FU as standard agent in combination with radiotherapy in rectal cancer. Cetuximab is a monoclonal antibody directed against the epidermal growth factor receptor. Both agents are active in the treatment of colorectal cancer and have demonstrated radiosensitising properties. The aim of this study was to assess the feasibility of combini...

Journal: :Reactions Weekly 2021

Journal: :Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research 2014
K Gerasimova M Avxentyeva O Rebrova

In RCT both tegafur + calcium folinate and capecitabine had a statistically signi cant advantage over 5- uorouracil + calcium folinate: the full and partial objective tumor response was achieved in more patients (table 1). There was no statistically signi cant difference between oral tegafur, both in monotherapy or in combination with calcium folinate, and capecitabine for advanced CRC treat...

Journal: :Oncology reports 2007
Noriaki Sawada Kumiko Kondoh Kazushige Mori

We have evaluated the antitumor activity of XELOX (a combination therapy of capecitabine (Xeloda) and oxaliplatin) in human colorectal and gastric cancer xenograft models. In human colorectal cancer model CXF280, antitumor activity of the combination at two-thirds of the maximum tolerated dose (MTD) was superior to that of each monotherapy at MTD. Furthermore, in human colorectal cancer model C...

2011
Bradford R Hirsch S Yousuf Zafar

5-Fluorouracil has been a mainstay in the treatment of colorectal cancer for nearly five decades; however, the use of oral formulations of the medication has been gaining increasing traction since capecitabine was approved for use in adjuvant settings by the US Food and Drug Administration in 2005. The use of capecitabine has since spread to a number of off-label indications, including the trea...

Journal: :Clinical cancer research : an official journal of the American Association for Cancer Research 2001
K Fujimoto-Ouchi Y Tanaka T Tominaga

Docetaxel and capecitabine are being prescribed for the treatment of breast cancer. In this study, we tried to identify the optimal administration schedule in combination therapy with these anticancer drugs in human cancer xenograft models. Capecitabine was given p.o. daily for 2 weeks (days 1-14), whereas docetaxel was given i.v. on day 1, day 8, or day 15 in a 3-week regimen to the mice beari...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید